439 related articles for article (PubMed ID: 14730101)
21. Effect of classic and atypical neuroleptics on cytochrome P450 3A (CYP3A) in rat liver.
Wójcikowski J; Haduch A; Daniel WA
Pharmacol Rep; 2012; 64(6):1411-8. PubMed ID: 23406751
[TBL] [Abstract][Full Text] [Related]
22. Promazine pharmacokinetics during concurrent treatment with tricyclic antidepressants.
Syrek M; Wójcikowski J; Daniel WA
Pol J Pharmacol; 1997; 49(6):453-62. PubMed ID: 9566049
[TBL] [Abstract][Full Text] [Related]
23. Involvement of human CYP1A isoenzymes in the metabolism and drug interactions of riluzole in vitro.
Sanderink GJ; Bournique B; Stevens J; Petry M; Martinet M
J Pharmacol Exp Ther; 1997 Sep; 282(3):1465-72. PubMed ID: 9316860
[TBL] [Abstract][Full Text] [Related]
24. The effect of ketoconazole on hepatic oxidative drug metabolism in the rat in vivo and in vitro.
Meredith CG; Maldonado AL; Speeg KV
Drug Metab Dispos; 1985; 13(2):156-62. PubMed ID: 2859162
[TBL] [Abstract][Full Text] [Related]
25. The atypical neuroleptics iloperidone and lurasidone inhibit human cytochrome P450 enzymes in vitro. Evaluation of potential metabolic interactions.
Danek PJ; Wójcikowski J; Daniel WA
Pharmacol Rep; 2020 Dec; 72(6):1685-1694. PubMed ID: 32279279
[TBL] [Abstract][Full Text] [Related]
26. Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes.
Campbell ME; Grant DM; Inaba T; Kalow W
Drug Metab Dispos; 1987; 15(2):237-49. PubMed ID: 2882985
[TBL] [Abstract][Full Text] [Related]
27. Effect of cytochrome P450 (CYP) inducers on caffeine metabolism in the rat.
Kot M; Daniel WA
Pharmacol Rep; 2007; 59(3):296-305. PubMed ID: 17652830
[TBL] [Abstract][Full Text] [Related]
28. A study on the metabolism of etoposide and possible interactions with antitumor or supporting agents by human liver microsomes.
Kawashiro T; Yamashita K; Zhao XJ; Koyama E; Tani M; Chiba K; Ishizaki T
J Pharmacol Exp Ther; 1998 Sep; 286(3):1294-300. PubMed ID: 9732391
[TBL] [Abstract][Full Text] [Related]
29. In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions.
Wójcikowski J; Danek PJ; Basińska-Ziobroń A; Pukło R; Daniel WA
Pharmacol Rep; 2020 Jun; 72(3):612-621. PubMed ID: 32219694
[TBL] [Abstract][Full Text] [Related]
30. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
Szakács T; Veres Z; Vereczkey L
Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
[TBL] [Abstract][Full Text] [Related]
31. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes.
Yao HT; Chang YW; Lan SJ; Yeh TK
Food Chem Toxicol; 2008 Feb; 46(2):645-53. PubMed ID: 17950511
[TBL] [Abstract][Full Text] [Related]
32. The relative contribution of human cytochrome P450 isoforms to the four caffeine oxidation pathways: an in vitro comparative study with cDNA-expressed P450s including CYP2C isoforms.
Kot M; Daniel WA
Biochem Pharmacol; 2008 Aug; 76(4):543-51. PubMed ID: 18619574
[TBL] [Abstract][Full Text] [Related]
33. Oxidative metabolism of monensin in rat liver microsomes and interactions with tiamulin and other chemotherapeutic agents: evidence for the involvement of cytochrome P-450 3A subfamily.
Nebbia C; Ceppa L; Dacasto M; Carletti M; Nachtmann C
Drug Metab Dispos; 1999 Sep; 27(9):1039-44. PubMed ID: 10460804
[TBL] [Abstract][Full Text] [Related]
34. Evidence for the involvement of several cytochromes P-450 in the first steps of caffeine metabolism by human liver microsomes.
Berthou F; Flinois JP; Ratanasavanh D; Beaune P; Riche C; Guillouzo A
Drug Metab Dispos; 1991; 19(3):561-7. PubMed ID: 1680620
[TBL] [Abstract][Full Text] [Related]
35. Regulation of thiol environment of the N-demethylation and ring hydroxylation of N,N-dimethyl-4-aminoazobenzene (DAB) by rat liver microsomes.
Levine WG
Drug Metab Dispos; 1986; 14(1):13-8. PubMed ID: 2868856
[TBL] [Abstract][Full Text] [Related]
36. Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms.
Tassaneeyakul W; Birkett DJ; McManus ME; Tassaneeyakul W; Veronese ME; Andersson T; Tukey RH; Miners JO
Biochem Pharmacol; 1994 May; 47(10):1767-76. PubMed ID: 8204093
[TBL] [Abstract][Full Text] [Related]
37. Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2.
Kinzig-Schippers M; Fuhr U; Zaigler M; Dammeyer J; Rüsing G; Labedzki A; Bulitta J; Sörgel F
Clin Pharmacol Ther; 1999 Mar; 65(3):262-74. PubMed ID: 10096258
[TBL] [Abstract][Full Text] [Related]
38. Effect of neuroleptics on cytochrome P450 2C11 (CYP2C11) in rat liver.
Haduch A; Wójcikowski J; Daniel WA
Pharmacol Rep; 2011; 63(6):1491-9. PubMed ID: 22358097
[TBL] [Abstract][Full Text] [Related]
39. Sertindole: new drug. Another "atypical" neuroleptic; QT prolongation.
Prescrire Int; 2007 Apr; 16(88):59-62. PubMed ID: 17458045
[TBL] [Abstract][Full Text] [Related]
40. In vitro metabolism of carbofuran by human, mouse, and rat cytochrome P450 and interactions with chlorpyrifos, testosterone, and estradiol.
Usmani KA; Hodgson E; Rose RL
Chem Biol Interact; 2004 Dec; 150(3):221-32. PubMed ID: 15560889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
